ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1389

Low Spinal Radiographic Progression After a Mean of 15 Years of Follow-up in a Cohort of Patients with Axial Spondyloarthritis

raquel granados1, Santiago Dans-Caballero1, Lourdes Ladehesa Pineda2, María Ángeles Puche Larrubia3, Desiree Ruiz Vilchez4, Maria del Carmen Abalos-Aguilera4, Alejandro Escudero-Contreras5, Eduardo Collantes Estévez6 and Clementina López Medina7, 1Rheumatology Department, Reina Sofia University Hospital, Cordoba/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain, 2Rheumatology Department Reina Sofia Universitary Hospital, Cordoba, Spain, 3Department of Rheumatology, Reina Sofia University Hospital, Cordoba, Spain, 4Rheumatology Department, Reina Sofia University Hospital/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain, 5Rheumatology Department, Reina Sofia University Hospital, Cordoba/Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Córdoba, Spain, 6Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Cordoba, Spain, 7Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris; Rheumatology Department, Reina Sofia Hospital, Cordoba / IMIBIC / University of Cordoba, Cordoba, Spain

Meeting: ACR Convergence 2023

Keywords: radiography, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Axial spondyloarthritis (axSpA) is characterized by progressive structural damage on the sacroiliac joints and/or the spine. Conventional radiology allows to assess radiology through available scales such as the mSASSS (modified Stoke Ankylosing Spondylitis Spinal Score) in the spine. However, scarce is the data on long-term radiographic progression and factors associated with such progression. The aim of this study was to evaluate the radiographic progression in the spine in patients with axSpA after a mean of 15 years of follow-up as well as the factors associated with such progression.

Methods: Patients with axSpA pertaining to the Reina Sofia University Hospital and included in the multicentre Spanish registry REGISPONSER between 2006-2007 were re-evaluated in 2021-2022. Spine (cervical and lumbar) radiographs were obtained with the aim to be compared with those obtained in 2007. Two trained blinded readers scored the mSASSS in radiographs from both visits (baseline and current). First, intraclass correlation coefficients (ICC) were obtained to evaluate the agreement between both readers in mSASSS. Mean mSASSS of both readers in both timepoints were calculated and the absolute progression (∆mSASSS) was evaluated. In addition, it was evaluated the mean and median progression per year dividing the ∆mSASSS by the years of follow-up in each patient. Then, the median progression per year was used to divide patients in “low progressors” and “high progressors”. Baseline characteristics between these two groups were compared using univariate analysis.

Results: A total of 77 axSpA patients with both baseline and current radiographs were included. A total of 53 (68.8%) were male and the mean disease duration was 10.15 (SD 9.2) years. All of them were naïve to bDMARD at baseline and 38% had radiographic sacroiliitis. The mean years of follow-up (i.e, mean time separating the radiographs) was 15 years (SD 3.3) (Figure 1). ICC between the two readers was moderate for mSASSS at baseline (0.73, 95%CI 0.26-0.88) and at the 15 years visit (0.65, 95%CI 0.11-0.84) (Figure 2). After a mean of 15y of follow-up, the mean progression was 0.54 (SD 0.55) points in mSASSS per year and the median progression was 0.38 points per year. A total of 37 (48%) patients were considered “low progressors” (i.e., median progression < 0.38 points per year) and 40 (52%) were considered as “high progressors” (i.e., median progression ≥0.38 points per year). The only significant variable associated with “high progression” was low back pain before the diagnosis (82.5% vs. 48.6%, p-value 0.003). Neither sex, smoking, disease duration, HLAB27 or c-reactive protein were associated with the “high progression” group (Table 1).

Conclusion: In this stablished axSpA population, the mean and median progression were 0.54 and 0.38 points in mSASSS per year respectively, which is lower than what has been reported in similar cohorts (i.e., change in 2 points per two years in mSASSS). Only low back pain was found as predictor of spinal radiographic progression.

Supporting image 1

Figure 1. Baseline Characteristics.

Supporting image 2

Figure 2. Two readers radiographic lecture

Supporting image 3

Table 1. Baseline population characteristics observed by two readers


Disclosures: r. granados: None; S. Dans-Caballero: None; L. Ladehesa Pineda: None; M. Puche Larrubia: None; D. Ruiz Vilchez: None; M. Abalos-Aguilera: None; A. Escudero-Contreras: None; E. Collantes Estévez: None; C. López Medina: AbbVie, 5, 6, Eli Lilly, 2, 5, 6, Janssen, 6, MSD, 6, Novartis, 2, 5, 6, UCB Pharma, 2, 5, 6.

To cite this abstract in AMA style:

granados r, Dans-Caballero S, Ladehesa Pineda L, Puche Larrubia M, Ruiz Vilchez D, Abalos-Aguilera M, Escudero-Contreras A, Collantes Estévez E, López Medina C. Low Spinal Radiographic Progression After a Mean of 15 Years of Follow-up in a Cohort of Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/low-spinal-radiographic-progression-after-a-mean-of-15-years-of-follow-up-in-a-cohort-of-patients-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-spinal-radiographic-progression-after-a-mean-of-15-years-of-follow-up-in-a-cohort-of-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology